Chemotherapy Spray Could Make Surgery Possible for More Peritoneal Mesothelioma Patients

ByAlex Strauss

chemotherapy sprayA technique that turns anti-cancer drugs into a chemotherapy spray could be a breakthrough for some peritoneal mesothelioma patients who were told they were not candidates for surgery. 

The procedure is called PIPAC. It stands for pressurized intraperitoneal aerosol chemotherapy. It allows doctors to apply cancer-killing medication directly to the site of peritoneal mesothelioma tumors. 

A new French study suggests that the chemotherapy spray, in combination with systemic chemotherapy, can shrink some tumors enough to completely remove them – even if doctors did not initially think resection was possible. 

The study tracked several cases of successful surgery after standard chemotherapy and PIPAC. The retrospective study shows patients who had surgery experienced much longer progression-free survival than those who did not. 

Standard Chemotherapy vs Chemotherapy Spray

Peritoneal mesothelioma is a type of cancer that grows on the lining of the abdomen. About 20 percent of mesothelioma patients have the peritoneal form of the disease.  

Surgery provides the best odds for peritoneal mesothelioma survival. Surgeons usually rinse the abdomen with heated chemotherapy drugs (HIPEC) after they remove the main tumors. This helps keep residual cells from seeding new mesothelioma tumors. The five-year survival rate for patients who have this combination ranges from 29% to 63%. 

But most peritoneal mesothelioma patients are not candidates for surgery and HIPEC. It is usually because their cancer is too advanced. These patients may have systemic chemotherapy with Alimta (pemetrexed) and a platinum-based drug to help slow the cancer down. 

The new research shows chemotherapy spray may be helpful for these patients. Standard chemotherapy poisons tumors from the inside. Chemotherapy spray attacks them from the outside. If the two techniques can shrink the tumors, surgeons may be able to remove them.

PIPAC, Chemotherapy, and Mesothelioma Survival

The French study focused on 26 peritoneal mesothelioma patients who had at least one PIPAC treatment. Twenty of them had never had surgery. Half of the patients had three or more treatments with the chemotherapy spray. 

Eight patients (31%) had side effects from the treatment, including two severe complications. But fourteen patients (54%) went on to have surgery and HIPEC. Almost all of these were successful. 

“All but one procedure among 14 patients (54%) secondarily treated by CRS-HIPEC were considered complete resections,” writes the study’s lead author Vahan Kepenekian of the University of Lyon. 

The mesothelioma patients who had chemotherapy spray and systemic chemotherapy had a median survival of 12 months. But those who were able to have surgery lived much longer without cancer regrowth than those who did not (33.5 months versus 7.4 months).

Dr. Kepenekian concludes, “For patients with initially non-resectable DMPM [peritoneal mesothelioma], PIPAC is feasible for treatment with neoadjuvant intent and could facilitate complete secondary resection.”

Sources:

Kepenekian, V, et al, “Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study”, October 28, 2021, Annals of Surgical Oncology, Online ahead of print, https://link.springer.com/article/10.1245/s10434-021-10983-2

Mirarabshahii, P, et al, “Diffuse malignant peritoneal mesothelioma – An update on treatment”, November 21, 2011, Cancer Treatment Reviews, https://www.cancertreatmentreviews.com/article/S0305-7372(11)00221-0/fulltext

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    ByAlex Strauss

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…